Physician profile
Ajay Behari
NPI 1902992845
$1,778.31
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $811 · 2020: $306 · 2021: $305 · 2022: $123 · 2023: $218 · 2024: $15.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $233.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $348.49 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $319.67 | 2019-2023 | Xywav |
| Boehringer Ingelheim Pharmaceuticals, INC. | $238.80 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $177.45 | 2019-2024 | Airsupra |
| Sunovion Pharmaceuticals INC. | $121.28 | 2019 | |
| Mylan Specialty L.P. | $83.36 | 2019-2023 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $56.05 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $52.00 | 2020-2021 | |
| Genzyme Corporation | $49.30 | 2020-2021 | |
| Genentech USA, INC. | $44.48 | 2019 | |
| Advanced Respiratory, INC | $36.17 | 2019 | |
| Shire North American Group INC | $33.54 | 2019 | |
| Alexion Pharmaceuticals, INC. | $26.31 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $24.88 | 2021 | |
| Electromed, INC. | $23.76 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $23.59 | 2023 | Prolastin-C Liquid |
| Novartis Pharmaceuticals Corporation | $23.12 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.82 | 2019 | |
| Resmed Corp | $19.89 | 2019 | |
| Philips North America LLC | $15.84 | 2021 | |
| Harmony Biosciences LLC | $14.25 | 2020 | |
| Axsome Therapeutics, INC. | $14.19 | 2023 | Sunosi |
| Merck Sharp & Dohme LLC | $11.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajay Behari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.